Medication info
Daplo Tablets 10 mg (Dapagliflozin Propanediol Hydrate)

Daplo Tablets 10 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Youngjin Pharmaceutical Co., Ltd.
Appearance
Yellow, biconvex, diamond-shaped film-coated tablet
Packaging
28 tablets/PTP [28 tablets (7 tablets/PTP x 4)]
Approval status
Active

MFDS item code 202300414 · Approved 2023.01.31 · Insurance code 642405140

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug therapy who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not use this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
Under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.

Ingredients

Manufacturer
Youngjin Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

  • Problems in blood sugar control in patients with type 2 diabetes
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be administered alone or in combination with other medications. Care must be taken regarding the occurrence of cardiovascular events in patients with cardiovascular diseases or risk factors among those whose blood sugar is not sufficiently controlled. This medication is effectively used for the treatment of type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug therapy who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not use this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

Under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.

Precautions

This medication should not be used in patients with allergies to its active ingredient or additives. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with a genetic intolerance to galactose, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medication. It is also not intended for patients undergoing kidney dialysis. Caution should be exercised when using this medication in patients with low fluid volume or impaired kidney function. This medication may lower blood pressure or temporarily change creatinine levels in the blood, affecting the kidneys. In particular, patients with impaired kidney function, the elderly, and those taking diuretics are at higher risk for hypotension or decreased fluid volume, necessitating careful monitoring of their condition before and after administration. The most common side effect of this medication is genital infections. Other possible side effects include urinary tract infections, hypoglycemia, dizziness, dry mouth, constipation, and weight loss. Additionally, rarely, serious side effects such as diabetic ketoacidosis, worsening kidney function, and necrotizing fasciitis may occur, so immediate consultation with healthcare professionals is necessary if symptoms appear. Pregnant women are advised not to take this medication, and it should be stopped immediately upon confirmation of pregnancy. Breastfeeding women are also recommended not to use this medication. The risk of hypoglycemia may be increased when this medication is used with drugs that can induce hypoglycemia, such as insulin or sulfonylureas, necessitating possible dosage adjustments. During the use of this medication, careful observation for symptoms of decreased fluid volume, hypotension, infection, and ketoacidosis is necessary, especially in elderly or patients with poor kidney function. The safety and efficacy of this medication in children have not been established, so it is not used in pediatric patients. In case of overdose, there is no specific antidote, and appropriate treatment should be given according to symptoms. Finally, this medication should be kept out of reach of children and stored in its original container.

Side effects

Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, decreased initial renal creatinine clearance during treatment, dyslipidemia, increased serum creatinine at the beginning of treatment, increased blood urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, acute pyelonephritis, chest pain, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chronic gastritis, diverticulosis, intra-abdominal air, frequent bowel movements, gastroenteritis, colorectal polyps, bowel perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disorders, gingival pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urinary stones, urinary abnormalities, increased blood lactate, lymphocytopenia, vitamin D deficiency, increased appetite, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unresponsiveness, nerve compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, herpes zoster, sinusitis, tonsillitis, herpes simplex, hordeolum, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, nail fungus, herpes simplex, swelling, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like symptoms, fatigue, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, discomfort in the vulva, menstrual irregularities, itching, urticaria, cold sweats, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 degrees Celsius and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow, biconvex, diamond-shaped film-coated tablet

Package unit

28 tablets/PTP [28 tablets (7 tablets/PTP x 4)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.